Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidAdam Aufderheide
    Ask Trek AI about this page

    Adam Aufderheide — Billing Profile & Reimbursement Data

    NPI 1982915344 · Medford, OR · Ophthalmology Physician

    Customize your policy alerts

    Sign up for Adam Aufderheide — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Adam Aufderheide is a ophthalmology physician provider located in Medford, Oregon. This profile covers 18 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationAdam Aufderheide
    Address748 State St
    CityMedford
    StateOR
    ZIP97504
    TaxonomyOphthalmology Physician
    NPI EnumeratedJune 30, 2010

    Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

    Payer SourceTotal Paid
    Medicare$2.8M
    Medicaid$0

    Key Findings

    This provider’s billing is effectively single‑payer: lifetime Medicare revenue is $2.8M while there is no Medicaid billing on file, indicating Medicare patients drive the practice’s scale and should be the primary focus for payer/provider analysis and contracting. The absence of Medicaid activity suggests limited participation in state‑program care pathways or a patient mix concentrated in Medicare-eligible populations.

    Revenue is highly concentrated in a small set of injectable drug codes: J0178 ($1.6M, 55.9% of Medicare revenue), J2777 ($457.6K, 16.1% of Medicare revenue), and J3490 ($177.4K, 6.2% of Medicare revenue) together account for 78.2% of this provider’s total Medicare revenue. This concentration shows the practice’s economics are dominated by high-value intravitreal therapeutics and related drug billing.

    Clinical/service-line mix points to a retina-focused ophthalmology practice: high-volume drug administrations (J0178, J2777, J2781, J2778) and intravitreal injection procedure 67028 (1.6K claims, $147.9K revenue, 5.2%) indicate routine anti-VEGF and other intravitreal therapies as core services. Supporting diagnostics are present too—notably OCT imaging—so the operation combines frequent in-office injections with retinal imaging and follow-up visits rather than being surgery-centric.

    Diagnostic imaging volume is an outlier relative to national peers: 92134 has 2.4K claims and $66.8K revenue and ranks #728 of 26868 providers nationally (97th percentile; extreme outlier), while established‑patient intermediate exams 92012 (948 claims, $59.7K) also ranks in the 97th percentile and is described as notably above typical national volume. These datapoints indicate unusually high throughput for retinal imaging and routine ophthalmic follow-up.

    Competitive standing on specific drug codes is mixed: J0178 (2.3K claims, $1.6M) ranks #392 of 3204 nationally (88th percentile), signaling a strong national position for aflibercept administration, whereas J2777 (15.8K claims, $457.6K) ranks #674 of 2039 (67th percentile) and J3490 ranks #753 of 2838 (73rd percentile), both consistent with typical national volumes. Additionally, J2781 (1.2K claims, $142.2K) ranks #80 of 490 (83rd percentile), indicating notable utilization of pegcetacoplan relative to the smaller cohort of providers billing that drug.

    Surgical retina procedures represent a small share of revenue and volume: vitrectomy/related CPTs such as 67042 (15 claims, $13K) and 67036 (18 claims, $11K) appear infrequently and together account for a minor fraction of Medicare revenue. This suggests the practice focuses on medical retina care and office‑based procedures rather than frequent operating-room surgery.

    Provider tenure is long-standing: NPI enumerated 2010-06-30 (~16 years ago), indicating a stable, established billing history in Medicare. That tenure combined with concentrated, repeatable billing for injections and imaging implies an operational model built around recurring treatment regimens and follow-up care rather than episodic care bursts.

    For payer strategy and network decisions, the practice’s economics point to drug reimbursement and outpatient injection workflows as key levers: the dominant revenue contribution from injectable drug codes and the lack of Medicaid billing mean negotiations, prior authorization workflows, and supply/infusion logistics tied to Medicare drug reimbursement will have outsized impact on this provider’s revenue and practice operations.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    18 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    J0178Injection, aflibercept, 1 mg2,310$690$1.6M
    J2777Injection, faricimab‑svoa, 0.1 mg15,780$30$457.6K
    J3490Unclassified drugs100$1,720$177.4K
    67028The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.1,640$90$147.9K
    J2781Injection, pegcetacoplan, intravitreal, 1 mg1,190$120$142.2K
    J2778Injection, ranibizumab, 0.1 mg570$180$105K
    92134The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.2,380$30$66.8K
    92012For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…950$60$59.7K
    92014An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…490$80$38.7K
    J7999Compounded drug, not otherwise classified190$70$13.6K

    Showing 1–10 of 18

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

    View: State1 / 2

    Full comparison — all codes billed, vs. state median

    18 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    J0178460840$680$623.7K
    J2777103010,050$30$527.6K
    J2781310690$120$102.6K
    J2778620400$180$87.8K
    67028570580$90$72.3K
    J3490115040$640$42.9K
    6703681030$1,000$29K
    6704291020$1,100$27.5K
    J79993150270$70$23.4K
    9201442440110$80$16K

    Showing 1–10 of 18

    Related Providers

    Other providers that share a Tax Identification Number (TIN) with Adam Aufderheide, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Retina Care Center, LLCOROphthalmology Physician$0$2.5M
    Rocio Diaz SanjurSDOphthalmology Physician$623.7K$0

    Nearby Providers

    Other providers in the same ZIP code as Adam Aufderheide, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    AsanteORGeneral Acute Care Hospital$0$29.7M
    Addictions Recovery Center, Inc.ORSubstance Abuse Rehabilitation Facility$0$29.2M
    Asante Physician PartnersORFamily Medicine Physician$0$27.2M
    Mercy Flights IncorporatedORAmbulance$3.6M$19.4M
    Providence Health & Services - OregonORGeneral Acute Care Hospital$0$20.9M
    Crc Health Oregon, LLCORMethadone Clinic$193K$13M
    James Kolby Robinson, DmdORPediatric Dentistry$0$11.6M
    Valley Immediate Care, LLCORUrgent Care Clinic/Center$0$9.4M
    Lincare IncORDurable Medical Equipment & Medical Supplies$0$7.1M
    Southern Oregon Pediatrics, LLPORPediatric Hospice and Palliative Medicine Physician$0$6.5M

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Medicare Revenue by CPT/HCPCS Code
    Claims Volume vs. Oregon Distribution
    Adam Aufderheide — 2 of 18 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Oregon